Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ARS Pharmaceuticals (SPRY) Change in Inventory: 2024-2025

Historic Change in Inventory for ARS Pharmaceuticals (SPRY) over the last 1 years, with Sep 2025 value amounting to -$963,000.

  • ARS Pharmaceuticals' Change in Inventory fell 626.23% to -$963,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year change of. This contributed to the annual value of $5.9 million for FY2024, which is N/A change from last year.
  • Per ARS Pharmaceuticals' latest filing, its Change in Inventory stood at -$963,000 for Q3 2025, which was down 120.13% from $4.8 million recorded in Q2 2025.
  • ARS Pharmaceuticals' Change in Inventory's 5-year high stood at $8.4 million during Q1 2025, with a 5-year trough of -$963,000 in Q3 2025.
  • Over the past 2 years, ARS Pharmaceuticals' median Change in Inventory value was $4.8 million (recorded in 2025), while the average stood at $3.6 million.
  • Data for ARS Pharmaceuticals' Change in Inventory shows a maximum YoY tumbled of 626.23% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows ARS Pharmaceuticals' Change in Inventory stood at $5.8 million in 2024, then plummeted by 626.23% to -$963,000 in 2025.
  • Its Change in Inventory was -$963,000 in Q3 2025, compared to $4.8 million in Q2 2025 and $8.4 million in Q1 2025.